General Information
Version
8.2
Revision date
2024-03-12
Product name
Citalopram Hydrobromide
CAS No.
59729-32-7
REACH No
is
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+56 2 2581 4934, +56 2 2 2473600, +56 2 2 6353800
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H336, H361d, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Reproductive toxicity, (Category H361d Suspected of damaging the unborn 2) child. Specific target organ toxicity - H336 May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system Long-term (chronic) aquatic H412 Harmful to aquatic life with long hazard, (Category 3) lasting effects.
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H336 May cause drowsiness or dizziness. H361d Suspected of damaging the unborn child. H412 Harmful to aquatic life with long lasting effects. H412 Harmful to aquatic life with long lasting effects. H361d Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
